Stockreport

Longeveron Shares End 3-Day Win Streak, Drop 31% [MarketWatch]

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF On Thursday, the company said the U.S. Food and Drug Administration granted rare-pediatric-disease designation to Lomecel-B for the treatment of hypoplastic left heart [Read more]